logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Wolffparkinsonwhite Syndrome

    FiltersReset Filters
    10 results

    • flecainide acetate

      (Flecainide Acetate)
      Amneal Pharmaceuticals LLC
      Usage: Flecainide is indicated for preventing paroxysmal supraventricular tachycardias (PSVT) and paroxysmal atrial fibrillation/flutter in patients without structural heart disease. It is also used for documented life-threatening ventricular arrhythmias. Its use is contraindicated in patients with recent myocardial infarction and chronic atrial fibrillation is not recommended.

    • lidocaine hydrochloride

      (LIDOCAINE HYDROCHLORIDE)
      Hospira, Inc.
      Usage: Lidocaine hydrochloride injection is indicated for the acute management of ventricular arrhythmias, particularly in cases related to acute myocardial infarction or during cardiac surgery.

    • mexiletine hydrochloride

      (MEXILETINE HYDROCHLORIDE)
      Leading Pharma, LLC
      Usage: Mexiletine hydrochloride capsules are indicated for treating documented life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia. Its use for lesser arrhythmias or asymptomatic ventricular premature contractions is not recommended. Treatment initiation should occur in a hospital setting.

    • mexiletine hydrochloride

      (mexiletine hydrochloride)
      Sun Pharmaceutical Industries, Inc.
      Usage: Mexiletine hydrochloride capsules are indicated for treating life-threatening documented ventricular arrhythmias, such as sustained ventricular tachycardia. Its use for less severe arrhythmias or asymptomatic ventricular premature contractions is generally not recommended. Hospital initiation of treatment is advised, as antiarrhythmic drugs do not enhance survival in these patients.

    • mexiletine hydrochloride

      (Mexiletine Hydrochloride)
      Rising Pharma Holdings, Inc.
      Usage: Mexiletine hydrochloride capsules are indicated for treating life-threatening documented ventricular arrhythmias, such as sustained ventricular tachycardia. Its use is not recommended for lesser arrhythmias or asymptomatic ventricular premature contractions. Initiation of treatment should occur in a hospital setting.

    • procainamide hydrochloride

      (Procainamide Hydrochloride)
      International Medication Systems, Limited
      Usage: Procainamide hydrochloride injection is indicated for treating life-threatening documented ventricular arrhythmias, like sustained ventricular tachycardia. It is not recommended for lesser arrhythmias or asymptomatic ventricular premature contractions. Treatment initiation should occur in a hospital due to potential severe side effects, including serious hematological disorders.

    • propafenone hcl

      (Propafenone hydrochloride)
      Actavis Pharma, Inc.
      Usage: Propafenone hydrochloride is indicated to prolong the time to recurrence of paroxysmal atrial fibrillation/flutter and supraventricular tachycardia in patients without structural heart disease, and to treat life-threatening ventricular arrhythmias. It should be initiated in a hospital setting and is not recommended for patients with chronic atrial fibrillation.

    • propafenone hydrochloride

      (PROPAFENONE HYDROCHLORIDE)
      Aurobindo Pharma Limited
      Usage: Propafenone hydrochloride is indicated for prolonging the time to recurrence of paroxysmal atrial fibrillation/flutter and paroxysmal supraventricular tachycardia in patients without structural heart disease, and for treating life-threatening ventricular arrhythmias. Its use in chronic atrial fibrillation and for lesser ventricular arrhythmias is not recommended.

    • sotalol hydrochloride

      (Sotalol Hydrochloride Tables AF)
      Bayshore Pharmaceuticals LLC
      Usage: Sotalol AF is indicated for maintaining normal sinus rhythm in symptomatic patients with atrial fibrillation or atrial flutter. It is reserved for those with severe symptoms and is not recommended for easily reversible cases. It also treats life-threatening ventricular arrhythmias but should not be substituted with other sotalol formulations.

    • sotalol hydrochloride

      (Sotalol Hydrochloride)
      Epic Pharma, LLC
      Usage: Sotalol hydrochloride tablets (AF) are indicated for maintaining normal sinus rhythm in symptomatic patients with atrial fibrillation/atrial flutter (AFIB/AFL). They are also used for life-threatening ventricular arrhythmias. Caution is advised due to potential serious side effects; not suitable for easily reversible AFIB/AFL cases.